Table 2.
Antibacterial potential of caffeic acid (CA) alone and in antibiotic-phytochemical combination against Staphylococcus aureus. The combined effect of CA and antibiotics was evaluated using plates with MHA enriched with the subinhibitory concentration of CA.
| Straina | CAb MICc (µg/mL) | Ed | E+CA | -Δ%e | DAf | DA+CA | -Δ% | FOXg | FOX+CA | -Δ% | VAh | VA+CA | -Δ% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S. aureus ATCC 25923 | 256 | 0.38 | 0.38 | 0 | 0.064 | 0.047 | -27 | 1 | 1 | 0 | 0.75 | 0.75 | 0 |
| S. aureus ATCC 43300 | 256 | 256 | 256 | 0 | 256 | 256 | 0 | 12 | 8 | -33 | 0.38 | 0.50 | -32 |
| S. aureus ATCC 6538 | 256 | 0.064 | 0.125 | 95 | 0.023 | <0.016 | -30 | 2 | 1 | -50 | 0.50 | 0.50 | 0 |
| S. aureus 1 | 1024 | 0.50 | 0.25 | -50 | 0.064 | 0.032 | -50 | 2 | 1.5 | -25 | 0.75 | 0.50 | -33 |
| S. aureus 2 | 512 | 0.50 | 0.38 | -24 | 0.064 | 0.064 | 0 | 0.75 | 0.75 | 0 | 0.38 | 0.75 | 97 |
| S. aureus 3 | 512 | 256 | 0.19 | <-99.99 | 0.023 | <0.016 | -30 | 1.5 | 0.38 | -75 | 0.50 | 0.50 | 0 |
| S. aureus 4 | 512 | 0.38 | 0.19 | -50 | 0.064 | 0.047 | -27 | 2 | 1 | -50 | 0.50 | 0.50 | 0 |
| S. aureus 5 | 512 | 256 | 4 | -98 | 0.094 | 0.064 | -32 | 256 | 24 | -91 | 0.75 | 0.50 | -33 |
| S. aureus 6 | 512 | 0.50 | 0.125 | -75 | 0.064 | <0.016 | -75 | 1.5 | 1.5 | 0 | 0.38 | 0.50 | 32 |
| S. aureus 7 | 256 | 0.38 | 0.19 | -50 | 0.032 | 0.032 | 0 | 1 | 1 | 0 | 0.50 | 0.38 | -24 |
| S. aureus 8 | 1024 | 0.19 | 0.19 | 0 | 0.032 | <0.016 | -50 | 1.5 | 0.50 | -67 | 0.38 | 0.38 | 0 |
| S. aureus 9 | 512 | 0.38 | 0.19 | -50 | 0.064 | <0.016 | -75 | 1 | 1 | 0 | 0.38 | 0.38 | 0 |
| S. aureus 10 | 512 | 32 | 3 | -91 | 0.047 | <0.016 | -66 | 2 | 0.75 | -63 | 0.38 | 0.38 | 0 |
| S. aureus 11 | 1024 | 0.38 | 0.19 | -50 | 0.047 | 0.032 | -32 | 1.5 | 0.75 | -50 | 0.38 | 0.19 | -50 |
| S. aureus 12 | 512 | 256 | 256 | 0 | 256 | 256 | 0 | 256 | 256 | 0 | 0.75 | 0.75 | 0 |
| S. aureus 13 | 512 | 256 | 0.125 | <-99.99 | 256 | 0.094 | <-99.99 | 32 | 12 | -63 | 0.75 | 0.50 | -33 |
| S. aureus 14 | 1024 | 256 | <0.016 | <-99.99 | 256 | <0.016 | <-99.99 | 256 | <0.016 | <-99.99 | 0.75 | <0.016 | -98 |
| S. aureus 15 | 1024 | 0.25 | 0.19 | -24 | 0.064 | 0.023 | -64 | 8 | 1.5 | -81 | 0.38 | 0.38 | 0 |
| S. aureus 16 | 1024 | 256 | 256 | 0 | 256 | 256 | 0 | 256 | 32 | -88 | 0.50 | 0.50 | 0 |
| S. aureus 17 | 512 | 256 | <0.016 | <-99.99 | 256 | <0.016 | <-99.99 | 256 | <0.016 | <-99.99 | 0.38 | <0.016 | -96 |
| S. aureus 18 | 512 | 0.38 | 0.094 | -75 | 0.047 | <0.016 | -66 | 6 | 0.75 | -88 | 0.50 | 0.50 | 0 |
| S. aureus 19 | 1024 | 256 | 256 | 0 | 256 | 256 | 0 | 256 | 64 | -75 | 0.50 | 0.50 | 0 |
| S. aureus 20 | 256 | 256 | <0.016 | <-99.99 | 256 | <0.016 | <-99.99 | 12 | <0.016 | <-99.99 | 0.38 | <0.016 | -96 |
| Median | 512 | 0.5 | 0.19 | -50 | 0.064 | 0.032 | -32 | 2 | 1 | -63 | 0.50 | 0.5 | 0 |
| p i | 0.0004 | 0.0003 | 0.0003 | 0.091 | |||||||||
a Staphylococcus aureus 1 ÷ 20: strains from intractable surgical wounds.
bCA: caffeic acid.
cMIC: minimum inhibitory concentration.
dE: erythromycin.
eMICs changes according to the formula [(MIC of antibiotic - MIC of antibiotic with CA) / MIC of antibiotic] x 100%.
fDA: clindamycin.
gFOX: cefoxitin.
hVA: vancomycin.
iWilcoxon Signed-Rank Test.